Abstract
Oral cancer, the sixth most common worldwide, is often diagnosed at an advanced stage, impacting patient survival and mortality. Liquid biopsy offers the potential for cancer diagnosis, enabling dynamic tumor monitoring and disease surveillance. Here we validates a novel diagnostic approach using optical images of dried micro-droplets (volume of one µl) of saliva samples on glass and platinum substrates, employing Logistic Regression and Support Vector Machine (SVM) models. For each model, accuracy, sensitivity, specificity, and area under the ROC curve were calculated. Our findings indicated that optical density and surface area (SA) obtained from optical images of microdroplets are suitable paramters of discriminating oral cavity squamous cell carcinoma and health individuals. SVM models demonstrate impressive accuracy of 88.10% on glass and 95.00% on Pt substrates, ensuring robust and accurate detection of oral cancer based on these salient features.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded by the Sao Paulo Research Foundation (FAPESP) grants #2021/10563-9 and #2016/08633-0; National Council for Scientific and Technological Development (CNPq) proc.311933/2021-1, 406761/2022-1 (INCT INTERAS).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Research Ethics Committee of Institute of Science and Technology of Sao Paulo State University gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.